Health Care
  • Japan could offer unapproved Ebola drug

    Japan could offer unapproved Ebola drug

    By Reuters

    TOKYO (Reuters) - Japan would like to offer a drug to help treat the deadly Ebola virus before the World Health Organization officially rules on its use, the country's top government spokesman said...

  • Roche to buy U.S. biotech firm InterMune for $8.3 billion

    Roche to buy U.S. biotech firm InterMune for $8.3 billion

    By Ben Hirschler and Caroline Copley, Reuters

    LONDON/ZURICH (Reuters) - Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment...

  • British Ebola victim flown home as Congo finds new outbreak

    British Ebola victim flown home as Congo finds new outbreak

    By Josephus Olu-Mammah and Kylie MacLellan, Reuters

    FREETOWN/LONDON (Reuters) - A British medical worker was flown home from West Africa on Sunday after becoming the first Briton infected in an Ebola epidemic, and a separate new outbreak of the...

  • WHO warns of 'shadow zones' and unreported Ebola cases

    WHO warns of 'shadow zones' and unreported Ebola cases

    By Stephanie Nebehay and Clair MacDougall, Reuters

    GENEVA/MONROVIA (Reuters) - Families hiding infected loved ones and the existence of "shadow zones" where medics cannot go mean the West African Ebola epidemic is even bigger than thought, the World...

  • 6 Reasons Obamacare Can Win the Senate for the GOP

    What ever happened to Obamacare -- the unpopular healthcare bill that was to be the Republicans big weapon as they battled for control of the Senate this fall? For sure, the Affordable Care Act has...